Best for
All-rounder
How to buy Dechra Pharmaceuticals shares | 3270p
Own Dechra Pharmaceuticals shares in just a few minutes. Share price changes are updated daily.
Fact checked
Dechra Pharmaceuticals PLC (DPH) is a leading drug manufacturers-general business based in the UK. It opened the day at 3272p after a previous close of 3266p. During the day the price has varied from a low of 3256p to a high of 3330p. The latest price was 3270p (25 minute delay). Dechra Pharmaceuticals is listed on the London Stock Exchange (LSE) and employs 1,889 staff. All prices are listed in pence sterling.
How to buy shares in Dechra Pharmaceuticals
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: DPH in this case.
- Research Dechra Pharmaceuticals shares. The platform should provide the latest information available.
- Buy your Dechra Pharmaceuticals shares. It's that simple.
Best for
Low-cost trading
Best for
US shares
Best for
Beginners
What's in this guide?
- Can I buy shares in Dechra Pharmaceuticals?
- Has coronavirus impacted Dechra Pharmaceuticals shares?
- Dechra Pharmaceuticals shares summary
- Compare share dealing platforms
- Is Dechra Pharmaceuticals stock a buy or sell?
- Dechra Pharmaceuticals performance over time
- Are Dechra Pharmaceuticals shares over-valued?
- Dechra Pharmaceuticals's financials
- How volatile are Dechra Pharmaceuticals shares?
- Does Dechra Pharmaceuticals pay a dividend?
- Other common questions
How has Coronavirus impacted Dechra Pharmaceuticals's share price?
Since the stock market crash in March caused by coronavirus, Dechra Pharmaceuticals's share price has had significant positive movement.
Its last market close was 3474p, which is 19.40% up on its pre-crash value of 2800p and 71.13% up on the lowest point reached during the March crash when the shares fell as low as 2030p.
If you had bought £1,000 worth of Dechra Pharmaceuticals shares at the start of February 2020, those shares would have been worth £855.36 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £1,238.13.
Dechra Pharmaceuticals share price
Use our graph to track the performance of DPH stocks over time.Dechra Pharmaceuticals shares at a glance
Information last updated 2020-12-18.
| Open | 3272p |
|---|---|
| High | 3330p |
| Low | 3256p |
| Close | 3270p |
| Previous close | 3266p |
| Change | 4p |
| Change % | 0.122% |
| Volume | 264,262 |
Information last updated 2020-12-27.
| 52-week range | 2016.3682p - 3596p |
|---|---|
| 50-day moving average | 3315.5293p |
| 200-day moving average | 3177.3098p |
| Wall St. target price | 2680.86p |
| PE ratio | 104.1464 |
| Dividend yield | 0.34p (1%) |
| Earnings per share (TTM) | 32.8p |
Invest in Dechra Pharmaceuticals shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Dechra Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Dechra Pharmaceuticals price performance over time
Historical closes compared with the last close of 3270p
| 1 week (2021-01-11) | -8.51% |
|---|---|
| 1 month (2020-12-18) | 3270 |
| 3 months (2020-10-16) | -5.98% |
| 6 months (2020-07-17) | 9.15% |
| 1 year (2020-01-17) | 15.38% |
|---|---|
| 2 years (2019-01-18) | 35.35% |
| 3 years (2018-01-18) | 62.04% |
| 5 years (2016-01-18) | 230.97% |
Is Dechra Pharmaceuticals under- or over-valued?
Valuing Dechra Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Dechra Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Dechra Pharmaceuticals's P/E ratio
Dechra Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 104x. In other words, Dechra Pharmaceuticals shares trade at around 104x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Dechra Pharmaceuticals's EBITDA
Dechra Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £84.5 million.
The EBITDA is a measure of a Dechra Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.
Dechra Pharmaceuticals financials
| Revenue TTM | £515.1 million |
|---|---|
| Operating margin TTM | 11.4% |
| Gross profit TTM | £291.6 million |
| Return on assets TTM | 3.22% |
| Return on equity TTM | 5.91% |
| Profit margin | 6.58% |
| Book value | 5.902p |
| Market capitalisation | £3.7 billion |
TTM: trailing 12 months
Dechra Pharmaceuticals share dividends
Dividend payout ratio: 10390.91% of net profits
Recently Dechra Pharmaceuticals has paid out, on average, around 10390.91% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Dechra Pharmaceuticals shareholders could enjoy a 1% return on their shares, in the form of dividend payments. In Dechra Pharmaceuticals's case, that would currently equate to about 0.34p per share.
Dechra Pharmaceuticals's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 5 November 2020 (the "ex-dividend date").
Dechra Pharmaceuticals share price volatility
Over the last 12 months, Dechra Pharmaceuticals's shares have ranged in value from as little as 2016.3682p up to 3596p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Dechra Pharmaceuticals's is 0.4899. This would suggest that Dechra Pharmaceuticals's shares are less volatile than average (for this exchange).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
Dechra Pharmaceuticals overview
Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians worldwide. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.
Frequently asked questions
More guides on Finder
-
How to buy Transportation and Logistics Systems shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares | $50.05
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares | $111.51
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares | $3.745
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy CloudCommerce shares | $0.1275
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares | $0.93
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares | $4.66
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares | 220p
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares | 33.5p
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert